Penumbra has announced that it recently launched its SwiftSET coil—a new, complex coil solution designed for adaptive embolisation.
According to the company, SwiftSET is engineered to optimise vessel wall apposition through its shape configuration, and facilitate smooth deployment and natural conformity to tight spaces for dense occlusion in small vessels.
SwiftSET expands the procedural capabilities of Penumbra’s Swift coil system, allowing physicians to set an anchor and fill with space-seeking SwiftPAC coils—attributes that make it well-suited for a variety of neurovascular conditions, including intracranial aneurysms, and other neurovascular abnormalities like arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs), the company claims in a recent press release.
“SwiftSET allows for efficient, controllable occlusion due to its design to begin anchoring in a vessel upon deployment,” said Benjamin Yim (John Muir Medical Center, Walnut Creek, USA). “Our early experience shows that deploying and setting this Swift coil in a targeted area of the vessel supports both precision and stability as embolisation progresses.”
Penumbra states that SwiftSET has a 0.135-inch primary diameter coil that is intended to provide volume and softness, while its shape configuration is designed to optimise vessel wall apposition, conforming to the vessel to promote occlusion.
